ENTPD1 and melanoma: Comprehensive analysis of the clinicopathologic and immune features identified Model 1, containing nodal status, P1 (CD39+CD103+PD-1+) T-cells per mm2, mitotic rate, Breslow thickness and presence of ulceration, weighted in that order, as the most accurate model to predict melanoma recurrence in patients with primary melanoma.